Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2012
At a glance
- Drugs Bardoxolone methyl (Primary)
- Indications Diabetic nephropathies; Renal impairment
- Focus Pharmacodynamics
- 23 Oct 2012 Planned end date changed from 1 Dec 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 23 Oct 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 07 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.